Coming December: ASH publishes its late-breaking abstracts. We’ll add the organizations presenting them.

Orca Bio at ASH 2026

Dec 12–15, 2026 New Orleans, LA ~30k attendees Website

Orca Bio exhibits at Booth 2029 at ASH 2026 in New Orleans. Orca Bio supports a symposium on managing myelodysplastic syndromes in the modern era. The program is about getting ahead of the disease with current approaches.

OrganizationASH 2026 Attendance
Orca Bio
Menlo Park, CA
Biotech
Late-stage company developing high-precision allogeneic T-cell immunotherapies, led by Orca-T in a Phase 3 trial for blood cancers.
Booth
Exhibiting at Booth 2029
Sat, Dec 1211:00am–5:00pmSun, Dec 1310:00am–5:00pmMon, Dec 1410:00am–2:00pm
Symposium
Fri Dec 11
3:00pm–6:00pm
MDS in the Modern Era: Getting Ahead of the 8-Ball
Moving myelodysplastic syndrome care toward early disease-modifying drugs, with hypomethylating agents for higher-risk disease and wider transplant access.
Leukemias

Explore the full ASH 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in New Orleans. Leave your work email and we’ll be in touch.

Privacy

Download the full ASH 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Orca Bio

Tell us what you sell and we’ll find the people at Orca Bio most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction